Literature DB >> 6097559

Oxygen-dependent protection of radiation lung damage in mice by WR 2721.

J D Down, G J Laurent, R J McAnulty, G G Steel.   

Abstract

The modification of early and late radiation damage to the mouse lung by oxygen and WR 2721 has been studied by measurement of breathing rate, lethality, pleural fluid and hydroxyproline content. Protection by hypoxia and sensitization by hyperoxia of early radiation pneumonitis were demonstrated. There was a tendency for the protective effect of WR 2721 to decrease as the breathed oxygen concentration was raised above normal levels. WR 2721 protection of the late damage was higher (PF = 1.6-1.65) than was seen for early pneumonitis (PF = 1.3-1.35) when either breathing rate or lethality were used. Protection factors (PF) gained from measurements of pleural fluid at a year after treatment were similar to those for other endpoints of late damage (PF = 1.7). In contrast, the measurement of fibrosis through determination of lung hydroxyproline at 1 year gave a somewhat lower protection factor for WR 2721. In the same experiments the degree of epilation on the dorsal thorax was scored at 6 weeks. One hundred per cent oxygen gave enhancement (dose enhancement factor (DEF) = 1.2), 9 per cent oxygen reduced damage (DEF less than 0.7) and WR 2721 gave PF values in excess of 1.4 at all oxygen concentrations used. This showed that the radiation response of hair follicles was more sensitive to WR 2721 or to changes of oxygen than the lung. The results presented indicate a competitive interaction between WR 2721 and oxygen for the same injury site causing a shift in the oxygen K curve to higher oxygen concentrations. The validity of applying functional or survival measurements to assess the extent of pulmonary fibrosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097559     DOI: 10.1080/09553008414551791

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  8 in total

1.  The relationship between functional assays of radiation response in the lung and target cell depletion.

Authors:  E L Travis; S L Tucker
Journal:  Br J Cancer Suppl       Date:  1986

2.  A preclinical rodent model of radiation-induced lung injury for medical countermeasure screening in accordance with the FDA animal rule.

Authors:  Isabel L Jackson; Puting Xu; Caroline Hadley; Barry P Katz; Ross McGurk; Julian D Down; Zeljko Vujaskovic
Journal:  Health Phys       Date:  2012-10       Impact factor: 1.316

3.  The nature and relevance of late lung pathology following localised irradiation of the thorax in mice and rats.

Authors:  J D Down
Journal:  Br J Cancer Suppl       Date:  1986

Review 4.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

Review 5.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

Review 6.  Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome.

Authors:  C R Culy; C M Spencer
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  A further comparison of pathologies after thoracic irradiation among different mouse strains: finding the best preclinical model for evaluating therapies directed against radiation-induced lung damage.

Authors:  Isabel L Jackson; Zeljko Vujaskovic; Julian D Down
Journal:  Radiat Res       Date:  2011-02-21       Impact factor: 2.841

8.  Revisiting strain-related differences in radiation sensitivity of the mouse lung: recognizing and avoiding the confounding effects of pleural effusions.

Authors:  Isabel L Jackson; Zeljko Vujaskovic; Julian D Down
Journal:  Radiat Res       Date:  2010-01       Impact factor: 2.841

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.